Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Prudencio, Mercedes ^a,b   Borchelt, David R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DETERGENT; HYBRID PROTEIN; MUTANT PROTEIN; SAPONIN; SYNTHETIC PEPTIDE; ANTIBODY; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; FAMILIAL DISEASE; GENE MUTATION; HUMAN; HUMAN CELL; MOTONEURON; PROTEIN CONFORMATION; PROTEIN FOLDING; SOLUBILITY; ANIMAL; CHEMISTRY; CHO CELL; CRICETULUS; DISEASE MODEL; GENETICS; HAMSTER; METABOLISM; MOUSE; MUTATION; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIBODIES; CHO CELLS; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; HEK293 CELLS; HUMANS; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; MUTATION; PROTEIN CONFORMATION; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS; SUPEROXIDE DISMUTASE;

EID: 81155151484     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-77     Document Type: Article

References (56)

1. Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Prudencio M, Hart PJ, Borchelt DR, Andersen PM, Hum Mol Genet 2009 18 3217 3226 10.1093/hmg/ddp260 19483195
2. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. Shibata N, Hirano A, Kobayashi M, Siddique T, Deng H-X, Hung W-Y, Kato T, Asayama K, J Neuropathol Exp Neurol 1996 55 481 490 10.1097/00005072-199604000-00011 8786408 (Pubitemid 26112102)
3. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1 gene: multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. Kato S, Shimoda M, Watanabe Y, Nakashima K, Takahashi K, Ohama E, J Neuropathol Exp Neurol 1996 55 1089 1101 8858006 (Pubitemid 26338021)
4. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, et al. Neuron 1997 18 327 338 10.1016/S0896-6273(00) 80272-X 9052802 (Pubitemid 27111114)
5. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, Cleveland DW, Science 1998 281 1851 1854 9743498 (Pubitemid 28450505)
6. Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation. Kato S, Horiuchi S, Liu J, Cleveland DW, Shibata N, Nakashima K, Nagai R, Hirano A, Takikawa M, Kato M, et al. Acta Neuropathol 2000 100 490 505 10.1007/s004010000226 11045671
7. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis. Stieber A, Gonatas JO, Gonatas NK, J Neurol Sci 2000 177 114 123 10.1016/S0022-510X(00)00351-8 10980307
8. Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus. Stieber A, Gonatas JO, Gonatas NK, J Neurol Sci 2000 173 53 62 10.1016/S0022-510X(99)00300- 7 10675580 (Pubitemid 30081776)
9. Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation. Kato S, Sumi-Akamaru H, Fujimura H, Sakoda S, Kato M, Hirano A, Takikawa M, Ohama E, Acta Neuropathol 2001 102 233 238 11585247 (Pubitemid 32816143)
10. Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues. Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD, Neurobiol Dis 2001 8 933 941 10.1006/nbdi.2001.0443 11741389 (Pubitemid 34017087)
11. Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase. Ohi T, Saita K, Takechi S, Nabesima K, Tashiro H, Shiomi K, Sugimoto S, Akematsu T, Nakayama T, Iwaki T, et al. J Neurol Sci 2002 197 73 78 10.1016/S0022-510X(02) 00054-0 11997070 (Pubitemid 34462148)
12. Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families. Arisato T, Okubo R, Arata H, Abe K, Fukada K, Sakoda S, Shimizu A, Qin XH, Izumo S, Osame M, et al. Acta Neuropathol 2003 106 561 568 10.1007/s00401-003-0763-5 14517684 (Pubitemid 37441613)
13. Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Sasaki S, Warita H, Murakami T, Shibata N, Komori T, Abe K, Kobayashi M, Iwata M, Acta Neuropathol 2005 109 247 255 10.1007/s00401-004-0939-7 15614580 (Pubitemid 41166593)
14. Motor neuron disease in transgenic mice with an H46R mutant SOD1 gene. Sasaki S, Nagai M, Aoki M, Komori T, Itoyama Y, Iwata M, J Neuropathol Exp Neurol 2007 66 517 524 10.1097/01.jnen.0000263868.84188.3b 17549011 (Pubitemid 46869693)
15. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL, Neuron 1995 14 1105 1116 10.1016/0896-6273(95)90259-7 7605627
16. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, Jenkins NA, Borchelt DR, Hum Mol Genet 2003 12 2753 2764 10.1093/hmg/ddg312 12966034 (Pubitemid 37407112)
17. An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Rakhit R, Robertson J, Vande VC, Horne P, Ruth DM, Griffin J, Cleveland DW, Cashman NR, Chakrabartty A, Nat Med 2007 13 754 759 10.1038/nm1559 17486090 (Pubitemid 46889748)
18. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brannstrom T, Gredal O, Nilsson P, Marklund SL, Brain 2004 127 73 88 10.1093/brain/awh005 14534160 (Pubitemid 38055347)
19. Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis mice. Basso M, Massignan T, Samengo G, Cheroni C, De Biasi S, Salmona M, Bendotti C, Bonetto V, J Biol Chem 2006 281 33325 33335 10.1074/jbc. M603489200 16943203 (Pubitemid 46043260)
20. A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. Karch CM, Borchelt DR, J Biol Chem 2008 283 13528 13537 10.1074/jbc.M800564200 18316367
21. Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. Prudencio M, Durazo A, Whitelegge JP, Borchelt DR, J Neurochem 2009 108 1009 1018 10.1111/j.1471-4159.2008.05839.x 19077113
22. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR, Proc Natl Acad Sci USA 2009 106 7774 7779 10.1073/pnas.0902505106 19416874
23. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. Boylan K, Yang C, Crook J, Overstreet K, Heckman M, Wang Y, Borchelt D, Shaw G, J Neurochem 2009 111 1182 1191 10.1111/j.1471-4159.2009.06386.x 19765193
24. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. Ezzi SA, Urushitani M, Julien JP, J Neurochem 2007 102 170 178 10.1111/j.1471-4159.2007.04531.x 17394546 (Pubitemid 46906269)
25. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. Gros-Louis F, Soucy G, Lariviere R, Julien JP, J Neurochem 2010 113 1188 1199 20345765
26. An examination of alpha B-crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosis. Karch CM, Borchelt DR, J Neurochem 2010 113 1092 1100 20067574
27. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, et al. Nat Neurosci 2010 13 1396 1403 10.1038/nn.2660 20953194
28. A novel action of histone deacetylase inhibitors in a protein aggresome disease model. Corcoran LJ, Mitchison TJ, Liu Q, Curr Biol 2004 14 488 492 10.1016/j.cub.2004.03.003 15043813 (Pubitemid 38431283)
29. Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. Zhang F, Zhu H, Biochim Biophys Acta 2006 1760 404 414 10.1016/j.bbagen.2005.11. 024 16431026
30. SUMO-1 modification increases human SOD1 stability and aggregation. Fei E, Jia N, Yan M, Ying Z, Sun Q, Wang H, Zhang T, Ma X, Ding H, Yao X, et al. Biochem Biophys Res Commun 2006 347 406 412 10.1016/j.bbrc.2006.06.092 16828461 (Pubitemid 44041431)
31. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. Matsumoto G, Stojanovic A, Holmberg CI, Kim S, Morimoto RI, J Cell Biol 2005 171 75 85 10.1083/jcb.200504050 16216923 (Pubitemid 41434603)
32. Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1. Witan H, Gorlovoy P, Kaya AM, Koziollek-Drechsler I, Neumann H, Behl C, Clement AM, Neurobiol Dis 2009 36 331 342 10.1016/j.nbd.2009.07.024 19660548
33. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, Lopes EC, Patch JD, Hill AF, Cheema SS, J Neurosci 2005 25 108 117 10.1523/JNEUROSCI.4253-04.2005 15634772 (Pubitemid 40110771)
34. The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. Urushitani M, Ezzi SA, Matsuo A, Tooyama I, Julien JP, FASEB J 2008 22 2476 2487 10.1096/fj.07-092783 18337461 (Pubitemid 351948665)
35. An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Prudencio M, Durazo A, Whitelegge JP, Borchelt DR, Hum Mol Genet 2010 19 4774 4789 10.1093/hmg/ddq408 20871097
36. Control of actin polymerization in live and permeabilized fibroblasts. Symons MH, Mitchison TJ, J Cell Biol 1991 114 503 513 10.1083/jcb.114.3.503 1860882 (Pubitemid 21909819)
37. Intracellular trafficking and subcellular distribution of a large array of HPMA copolymers. Callahan J, Kopeckov P, Kopecek J, Biomacromolecules 2009 10 1704 1714 10.1021/bm801514x 21197960
38. Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Crapo JD, Oury T, Rabouille C, Slot JW, Chang L-Y, Proc Natl Acad Sci USA 1992 89 10405 10409 10.1073/pnas.89.21.10405 1332049
39. Colocalization of 14-3-3 proteins with SOD1 in Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis cases and the animal model. Okamoto Y, Shirakashi Y, Ihara M, Urushitani M, Oono M, Kawamoto Y, Yamashita H, Shimohama S, Kato S, Hirano A, et al. PLoS ONE 2011 6 20427 10.1371/journal.pone.0020427 21655264
40. Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Zetterstrom P, Stewart HG, Bergemalm D, Jonsson PA, Graffmo KS, Andersen PM, Brannstrom T, Oliveberg M, Marklund SL, Proc Natl Acad Sci USA 2007 104 14157 14162 10.1073/pnas.0700477104 17715066 (Pubitemid 350003351)
41. Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Karumbayaram S, Kelly TK, Paucar AA, Roe AJ, Umbach JA, Charles A, Goldman SA, Kornblum HI, Wiedau-Pazos M, Dis Model Mech 2009 2 189 195 10.1242/dmm.002113 19259395
42. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR, Neurobiol Dis 2002 10 128 138 10.1006/nbdi.2002.0498 12127151 (Pubitemid 34775466)
43. Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Liu HN, Sanelli T, Horne P, Pioro EP, Strong MJ, Rogaeva E, Bilbao J, Zinman L, Robertson J, Ann Neurol 2009 66 75 80 10.1002/ana.21704 19670443
44. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, Jacobsson J, Rosquist R, Marklund SL, Brannstrom T, PLoS ONE 2010 5 11552 10.1371/journal.pone.0011552 20644736
45. Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP, Dev Dynamics 1992 194 209 221 10.1002/aja.1001940306
46. Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. Niwa J, Yamada S, Ishigaki S, Sone J, Takahashi M, Katsuno M, Tanaka F, Doyu M, Sobue G, J Biol Chem 2007 282 28087 28095 10.1074/jbc.M704465200 17666395 (Pubitemid 47529492)
47. Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation. Witan H, Kern A, Koziollek-Drechsler I, Wade R, Behl C, Clement AM, Hum Mol Genet 2008 17 1373 1385 10.1093/hmg/ddn025 18211954 (Pubitemid 351627334)
48. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K, Rutkowski DT, Kaufman RJ, Ruse CI, Yates JR III, et al. Proc Natl Acad Sci USA 2009 106 1392 1397 10.1073/pnas.0813045106 19171884
49. Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis. Chen T, Benmohamed R, Arvanites AC, Ralay RH, Morimoto RI, Ferrante RJ, Watterson DM, Kirsch DR, Silverman RB, Bioorg Med Chem 2011 19 613 622 10.1016/j.bmc.2010.10. 052 21095130
50. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. Ilieva H, Polymenidou M, Cleveland DW, J Cell Biol 2009 187 761 772 10.1083/jcb.200908164 19951898
51. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, et al. Science 2003 302 113 117 10.1126/science.1086071 14526083 (Pubitemid 37210700)
52. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR, Neurobiol Dis 2005 20 943 952 10.1016/j.nbd.2005.06.005 16046140 (Pubitemid 41619369)
53. Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: {alpha}B-crystallin modulates aggregation. Wang J, Xu G, Li H, Gonzales V, Fromholt D, Karch C, Copeland NG, Jenkins NA, Borchelt DR, Hum Mol Genet 2005 14 2335 2347 10.1093/hmg/ddi236 16000321 (Pubitemid 41417996)
54. High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Wang J, Xu G, Borchelt DR, Neurobiol Dis 2002 9 139 148 10.1006/nbdi.2001.0471 11895367 (Pubitemid 34261210)
55. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW, Proc Natl Acad Sci USA 1995 92 954 958 10.1073/pnas.92.4.954 7862672
56. Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice. Borchelt DR, Wong PC, Becher MW, Pardo CA, Lee MK, Xu ZS, Thinakaran G, Jenkins NA, Copeland NG, Sisodia SS, et al. Neurobiol Dis 1998 5 27 35 10.1006/nbdi.1998.0178 9702785 (Pubitemid 28361649)